Allied Biotech Corporation (TPEX:1780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.00
-0.40 (-1.52%)
Mar 9, 2026, 1:17 PM CST
43.65%
Market Cap 2.51B
Revenue (ttm) 821.81M
Net Income (ttm) 94.59M
Shares Out 96.24M
EPS (ttm) 0.98
PE Ratio 26.62
Forward PE n/a
Dividend 1.00 (3.79%)
Ex-Dividend Date Jul 17, 2025
Volume 234,502
Average Volume 161,092
Open 25.90
Previous Close 26.40
Day's Range 25.70 - 26.55
52-Week Range 15.30 - 27.50
Beta -0.06
RSI 58.30
Earnings Date Mar 12, 2026

About Allied Biotech

Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. The company also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutei... [Read more]

Sector Healthcare
Founded 2001
Employees 40
Stock Exchange Taipei Exchange
Ticker Symbol 1780
Full Company Profile

Financial Performance

In 2024, Allied Biotech's revenue was 806.92 million, an increase of 12.00% compared to the previous year's 720.43 million. Earnings were 100.94 million, an increase of 3.62%.

Financial Statements

News

There is no news available yet.